Procaps Group, S.A. (PROC) News

Procaps Group, S.A. (PROC): $2.40

0.00 (0.00%)

POWR Rating

Component Grades

Momentum

D

Stability

C

Sentiment

Quality

B

Add PROC to Watchlist
Sign Up

Filter PROC News Items

PROC News Results

Date Symbol Company Title Start End Change POWR Rating
Loading, please wait...

PROC News Highlights

  • For PROC, its 30 day story count is now at 2.
  • Over the past 5 days, the trend for PROC's stories per day has been choppy and unclear. It has oscillated between 1 and 1.

Latest PROC News From Around the Web

Below are the latest news stories about PROCAPS GROUP SA that investors may wish to consider to help them evaluate PROC as an investment opportunity.

PROC Stock Earnings: Procaps Gr Beats EPS, Beats Revenue for Q3 2023

PROC stock results show that Procaps Gr beat analyst estimates for earnings per share and beat on revenue for the third quarter of 2023.

InvestorPlace Earnings on InvestorPlace | December 27, 2023

Procaps Group Reports Third Quarter 2023 Results

MIAMI & BARRANQUILLA, Colombia, December 26, 2023--Procaps Group Reports Third Quarter 2023 Results

Yahoo | December 26, 2023

Statement from the Board of Directors of Procaps Group

MIAMI & BARRANQUILLA, Colombia, December 21, 2023--Statement from the Board of Directors of Procaps Group

Yahoo | December 21, 2023

Procaps Group and Genomma Lab Announce a Strategic Agreement to Manufacture and Market Softgel Products in Latin America

Procaps Group (NASDAQ: PROC) ("Procaps"), a leading integrated international healthcare and pharmaceutical services company, and Genomma Lab Internacional, S.A.B. de C.V. (BMV: LABB; "Genomma"), the leading pharmaceutical and personal care company in Latin America, today announced a strategic agreement to develop, manufacture and market five Softgel products within Latin America. Through the partnership, Procaps will manufacture and Genomma will market and distribute the products.

Yahoo | November 30, 2023

Procaps Group Announces Appointment of Jose Antonio Vieira as Chief Executive Officer Starting 2024

MIAMI & BARRANQUILLA, Colombia, November 22, 2023--Procaps Group Announces Appointment of Jose Antonio Vieira as Chief Executive Officer Starting 2024

Yahoo | November 22, 2023

Procaps Group Update on Third Quarter Results

MIAMI & BARRANQUILLA, Colombia, November 14, 2023--Procaps Group Update on Third Quarter Results

Yahoo | November 14, 2023

Procaps Group to Report Third Quarter and Nine Months 2023 Results on Tuesday November 14, 2023

MIAMI & BARRANQUILLA, Colombia, November 10, 2023--Procaps Group to Report Third Quarter and Nine Months Results on Tuesday November 14 and Host Conference Call on Thursday November 16 at 10:30a.m. ET

Yahoo | November 10, 2023

Procaps Group Wins First Place in Ranking of Innovative Companies in the Pharma Sector in Colombia

MIAMI & BARRANQUILLA, Colombia, October 30, 2023--Procaps Group Wins First Place in Ranking of Innovative Companies in the Pharma Sector in Colombia

Yahoo | October 30, 2023

Procaps Appoints Sandra Sánchez y Oldenhage to Board of Directors

MIAMI & BARRANQUILLA, Colombia, October 23, 2023--Procaps Appoints Sandra Sánchez y Oldenhage to Board of Directors

Yahoo | October 23, 2023

Procaps Group to Participate at CPHI Barcelona 2023

MIAMI & BARRANQUILLA, Colombia, October 16, 2023--Procaps Group (NASDAQ: PROC) ("Procaps"), a leading integrated LatAm healthcare and pharmaceutical conglomerate, announced today that it will participate at the CPHI Barcelona 2023, that will take place from October 24th to October 26th, continuing with our two-decade presence in the conference.

Yahoo | October 16, 2023


Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!